Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 21,535 clinical trials worldwide
Search
Showing 15201-15250 of 21,535 trials
Active filters:
Status: Active, not recruiting
Clinical Trials (21,535)
NCT03731572
Hip Muscle Power, Lateral Balance Function, and Falls in Aging
NA
Active, not recruiting
100 participants
Started: Sep 16, 2019 · Completed: Dec 31, 2025
1 condition
2 sponsors
1 location
NCT04119037
Cordotomy in Reducing Pain in Patients With Advanced Cancer
NA
Active, not recruiting
27 participants
Started: Sep 16, 2019 · Completed: Dec 1, 2025
1 condition
3 sponsors
1 location
NCT03937128
Improving Employment and Reducing Recidivism Among Prison Offenders Via Virtual Interview Training Tool
NA
Active, not recruiting
150 participants
Started: Sep 16, 2019 · Completed: Dec 1, 2025
1 condition
2 sponsors
1 location
NCT03970226
Tocilizumab in Children With ACP
EARLY_PHASE1
Active, not recruiting
9 participants
Started: Sep 16, 2019 · Completed: Dec 31, 2025
1 condition
3 sponsors
1 location
NCT03992404
Study to Compare the Efficacy and Safety of NT 201 (Botulinum Toxin) With Placebo for the Treatment of Lower Limb Spasticity Caused by Stroke or Traumatic Brain Injury
PHASE3
Active, not recruiting
603 participants
Started: Sep 16, 2019 · Completed: Apr 30, 2027
1 condition
1 sponsor
71 locations
NCT04353752
Observational Trial of the Longitudinal Effects of CFTR Modulator Drugs
N/A
Active, not recruiting
80 participants
Started: Sep 16, 2019 · Completed: Dec 31, 2025
1 condition
2 sponsors
1 location
NCT04094038
The Effect of Intradialytic Parenteral Nutrition on Nutritional Status and Quality of Life in Hemodialysis Patients
PHASE4
Active, not recruiting
166 participants
Started: Sep 16, 2019 · Completed: Sep 30, 2025
4 conditions
2 sponsors
2 locations
NCT04109586
Diet and Fat Mass After Traumatic Spinal Cord Injury
NA
Active, not recruiting
56 participants
Started: Sep 15, 2019 · Completed: Sep 30, 2025
3 conditions
3 sponsors
1 location
NCT04089943
The Role of microRNA-210 in Regulating Oxidative Stress in Patients With PAD
NA
Active, not recruiting
230 participants
Started: Sep 15, 2019 · Completed: Aug 25, 2025
4 conditions
2 sponsors
2 locations
NCT03972202
The Role of Cerebellum in Speech
NA
Active, not recruiting
660 participants
Started: Sep 15, 2019 · Completed: May 31, 2025
3 conditions
4 sponsors
3 locations
NCT04087772
Enhancing School-Based Violence Prevention
NA
Active, not recruiting
4,840 participants
Started: Sep 13, 2019 · Completed: Dec 31, 2025
1 condition
2 sponsors
1 location
NCT04068610
COLUMBIA-1: Novel Oncology Therapies in Combination With Chemotherapy and Bevacizumab as First- Line Therapy in MSS-CRC
PHASE1/PHASE2
Active, not recruiting
61 participants
Started: Sep 13, 2019 · Completed: Nov 24, 2025
1 condition
1 sponsor
21 locations
NCT03259503
Olaparib and High-Dose Chemotherapy in Treating Patients With Relapsed or Refractory Lymphomas Undergoing Stem Cell Transplant
PHASE1
Active, not recruiting
50 participants
Started: Sep 13, 2019 · Completed: Jun 30, 2028
5 conditions
2 sponsors
1 location
NCT04013542
Ipilimumab and Nivolumab in Combination With Radiation Therapy in Treating Patients With Stage 2-3 Non-small Lung Cancer
PHASE1
Active, not recruiting
21 participants
Started: Sep 13, 2019 · Completed: Dec 31, 2027
12 conditions
2 sponsors
1 location
NCT04062266
AZA + Venetoclax as Maintenance Therapy in Patients With AML in Remission
PHASE2
Active, not recruiting
50 participants
Started: Sep 13, 2019 · Completed: Oct 31, 2030
6 conditions
3 sponsors
1 location
NCT03661255
Promoting Community Conversations About Research to End Native Youth Suicide in Rural Alaska
NA
Active, not recruiting
1,491 participants
Started: Sep 12, 2019 · Completed: Dec 15, 2025
1 condition
4 sponsors
1 location
NCT06321666
Response Evaluation of Cancer Therapeutics in Metastatic Breast Cancer to the Bone
NA
Active, not recruiting
58 participants
Started: Sep 12, 2019 · Completed: Dec 31, 2024
1 condition
1 sponsor
1 location
NCT03920007
Study of Subretinally Injected ATSN-101 Administered in Patients With Leber Congenital Amaurosis Caused by Biallelic Mutations in GUCY2D
PHASE1/PHASE2
Active, not recruiting
15 participants
Started: Sep 12, 2019 · Completed: May 19, 2027
3 conditions
1 sponsor
2 locations
NCT04121455
Glioblastoma Treatment With Irradiation and Olaptesed Pegol (NOX-A12) in MGMT Unmethylated Patients
PHASE1/PHASE2
Active, not recruiting
117 participants
Started: Sep 12, 2019 · Completed: Dec 31, 2028
1 condition
1 sponsor
6 locations
NCT03984695
Sexual Health Empowerment for Women's Health
NA
Active, not recruiting
279 participants
Started: Sep 11, 2019 · Completed: Mar 31, 2025
4 conditions
2 sponsors
1 location
NCT04088851
"Hepatic Substrate Flux Rates in Type 2 Diabetes"
NA
Active, not recruiting
23 participants
Started: Sep 11, 2019 · Completed: Dec 31, 2025
1 condition
2 sponsors
1 location
NCT04027647
Phase 2 Study of Dacomitinib in NSCLC
PHASE2
Active, not recruiting
118 participants
Started: Sep 11, 2019 · Completed: Mar 31, 2026
5 conditions
2 sponsors
9 locations
NCT04025840
Perioperative Epidural Block and Dexamethasone in Pancreatic Cancer Surgery
PHASE4
Active, not recruiting
260 participants
Started: Sep 11, 2019 · Completed: Nov 30, 2026
5 conditions
3 sponsors
1 location
NCT04076059
An Efficacy and Safety Study of Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus ADT in Chinese Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC)
PHASE3
Active, not recruiting
180 participants
Started: Sep 11, 2019 · Completed: Dec 31, 2028
1 condition
1 sponsor
28 locations
NCT04145882
Efficacy of Additional Osteotomies to Correct Hallux Valgus
NA
Active, not recruiting
515 participants
Started: Sep 11, 2019 · Completed: Sep 11, 2026
1 condition
1 sponsor
4 locations
NCT03808558
Phase 2 Study of TVB-2640 in KRAS Non-Small Cell Lung Carcinomas
PHASE2
Active, not recruiting
18 participants
Started: Sep 11, 2019 · Completed: Dec 1, 2026
1 condition
4 sponsors
2 locations
NCT06515171
Efficacy and Safety of Bowel Preparation for Patency Capsule in CD Patients Who Previously Failed Patency Capsule
N/A
Active, not recruiting
400 participants
Started: Sep 11, 2019 · Completed: Jul 1, 2025
2 conditions
1 sponsor
1 location
NCT03620903
Efficacy of First Line B-RI for Treatment Naive Waldenström's Macroglobulinemia
PHASE2
Active, not recruiting
53 participants
Started: Sep 11, 2019 · Completed: Sep 30, 2029
1 condition
6 sponsors
12 locations
NCT04078750
PLATO - Medication Adherence in Transplant Recipients
NA
Active, not recruiting
99 participants
Started: Sep 10, 2019 · Completed: Dec 31, 2024
4 conditions
1 sponsor
2 locations
NCT04176588
A Phase 3 Study of Etrasimod in Subjects With Moderately to Severely Active Ulcerative Colitis
PHASE3
Active, not recruiting
341 participants
Started: Sep 10, 2019 · Completed: Oct 31, 2024
1 condition
1 sponsor
1 location
NCT03970746
Safety, Immunogenicity and Preliminary Clinical Activity Study of PDC*lung01 Cancer Vaccine in NSCLC
PHASE1/PHASE2
Active, not recruiting
73 participants
Started: Sep 10, 2019 · Completed: Dec 31, 2025
1 condition
1 sponsor
16 locations
NCT03927820
A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR)
NA
Active, not recruiting
914 participants
Started: Sep 9, 2019 · Completed: Jun 30, 2026
2 conditions
1 sponsor
1 location
NCT04062305
nTMS in Planning Stereotactic Radiosurgery in Patients With Brain Metastases in the Motor Cortex
NA
Active, not recruiting
22 participants
Started: Sep 9, 2019 · Completed: May 6, 2027
2 conditions
2 sponsors
1 location
NCT03796767
Salvage Oligometastasectomy and Radiation Therapy in Recurrent Prostate Cancer
PHASE2
Active, not recruiting
20 participants
Started: Sep 9, 2019 · Completed: Jun 30, 2026
6 conditions
1 sponsor
1 location
NCT04196465
Phase II Study of Neoadjuvant Immune Checkpoint Inhibitor in Patients With Resectable Gastrointestinal Cancers
PHASE2
Active, not recruiting
48 participants
Started: Sep 9, 2019 · Completed: Sep 26, 2026
3 conditions
1 sponsor
1 location
NCT04046913
The ADDapt Diet in Reducing Crohn's Disease Inflammation
NA
Active, not recruiting
154 participants
Started: Sep 9, 2019 · Completed: Aug 20, 2024
2 conditions
4 sponsors
1 location
NCT04096885
The Inselspital Surgical Cohort Study
N/A
Active, not recruiting
1,226 participants
Started: Sep 9, 2019 · Completed: Feb 28, 2028
1 condition
1 sponsor
1 location
NCT04049695
Improving Cognition After Cancer
NA
Active, not recruiting
253 participants
Started: Sep 9, 2019 · Completed: Feb 1, 2025
2 conditions
1 sponsor
1 location
NCT03908177
Comparison of Clinical Performance and Safety of Zirconia vs. Titanium Implants: a Multi-national RCT.
NA
Active, not recruiting
124 participants
Started: Sep 7, 2019 · Completed: Aug 29, 2025
1 condition
2 sponsors
3 locations
NCT03949127
Efficacy of an Exercise Program for Patients With Femoro-acetabular Impingement
NA
Active, not recruiting
95 participants
Started: Sep 6, 2019 · Completed: Apr 30, 2024
1 condition
2 sponsors
1 location
NCT04120493
Safety and Proof-of-Concept (POC) Study With AMT-130 in Adults With Early Manifest Huntington's Disease
PHASE1/PHASE2
Active, not recruiting
43 participants
Started: Sep 6, 2019 · Completed: Dec 31, 2029
1 condition
1 sponsor
12 locations
NCT03368729
Niraparib in Combination With Trastuzumab in Metastatic HER2+ Breast Cancer
PHASE1/PHASE2
Active, not recruiting
46 participants
Started: Sep 6, 2019 · Completed: Dec 30, 2026
2 conditions
6 sponsors
7 locations
NCT03844048
An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial
PHASE3
Active, not recruiting
165 participants
Started: Sep 6, 2019 · Completed: Feb 28, 2026
6 conditions
1 sponsor
56 locations
NCT04270266
Mind-Body Medicine for the Improvement of Quality of Life in Adolescents and Young Adults Coping With Lymphoma
NA
Active, not recruiting
71 participants
Started: Sep 6, 2019 · Completed: Dec 21, 2026
1 condition
2 sponsors
1 location
NCT03950232
An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis
PHASE3
Active, not recruiting
778 participants
Started: Sep 5, 2019 · Completed: Jun 19, 2029
1 condition
2 sponsors
693 locations
NCT04032964
Dose Finding Study of L19TNF and Doxorubicin in Patients With STS
PHASE1
Active, not recruiting
2 participants
Started: Sep 5, 2019 · Completed: Dec 31, 2024
1 condition
1 sponsor
1 location
NCT04078295
A Study of E7389 Liposomal Formulation (E7389-LF) Plus Nivolumab in Participants With Solid Tumor
PHASE1/PHASE2
Active, not recruiting
125 participants
Started: Sep 5, 2019 · Completed: Mar 31, 2026
1 condition
2 sponsors
19 locations
NCT03982381
SGLT2 Inhibitor or Metformin As Standard Treatment of Early Stage Type 2 Diabetes
PHASE4
Active, not recruiting
2,067 participants
Started: Sep 5, 2019 · Completed: Oct 15, 2025
1 condition
5 sponsors
1 location
NCT04028570
A Feasibility Study Evaluating Surgery for Mesothelioma After Radiation Therapy Using Extensive Pleural Resection
NA
Active, not recruiting
12 participants
Started: Sep 5, 2019 · Completed: Apr 30, 2025
1 condition
1 sponsor
1 location
NCT03832998
Efficacy and Safety of Erenumab in Pediatric Subjects With Chronic Migraine
PHASE3
Active, not recruiting
284 participants
Started: Sep 5, 2019 · Completed: Jan 9, 2026
1 condition
2 sponsors
101 locations
Previous
1
More pages
302
303
304
305
306
307
308
More pages
431
Next